A few years ago the Office of the Director of National Intelligence established a “Biological Sciences Experts Group” consisting of scientists from industry and academia to advise the intelligence community on the threat of biological weapons proliferation and related matters. But not a single fact concerning the Group’s actions or accomplishments can be publicly disclosed, the ODNI said last week in response (pdf) to a Freedom of Information Act request.
As is often the case, a bit more about the Group can be learned through unofficial channels, as previously reported in Secrecy News (“Experts Advise IC on Classified Biosecurity Activities,” April 13, 2010).
By preparing credible, bipartisan options now, before the bill becomes law, we can give the Administration a plan that is ready to implement rather than another study that gathers dust.
Even as companies and countries race to adopt AI, the U.S. lacks the capacity to fully characterize the behavior and risks of AI systems and ensure leadership across the AI stack. This gap has direct consequences for Commerce’s core missions.
The last remaining agreement limiting U.S. and Russian nuclear weapons has now expired. For the first time since 1972, there is no treaty-bound cap on strategic nuclear weapons.
As states take up AI regulation, they must prioritize transparency and build technical capacity to ensure effective governance and build public trust.